Works matching IS 0937941X AND DT 2014 AND VI 25 AND IP 7


Results: 21
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate

    Published in:
    Osteoporosis International, 2014, v. 25, n. 7, p. 1953, doi. 10.1007/s00198-014-2692-7
    By:
    • Brown, J.;
    • Roux, C.;
    • Ho, P.;
    • Bolognese, M.;
    • Hall, J.;
    • Bone, H.;
    • Bonnick, S.;
    • Bergh, J.;
    • Ferreira, I.;
    • Dakin, P.;
    • Wagman, R.;
    • Recknor, C.
    Publication type:
    Article
    18
    19
    20
    21